US Oncology Holdings Inc Leadership

As Chief Executive Officer, Glen Laschober brings a broad perspective from working within healthcare service organizations that address the dynamic needs of healthcare systems, physicians, patients and payers. Glen has 30 years’ experience leading the senior management teams of innovative, market defining, high growth healthcare service businesses. Prior to Cardon Outreach, Glen was Chief Operating Officer of Prime Therapeutics, a leading pharmacy benefit management company where he oversaw strategy, business operations and technology. Before Prime Therapeutics, Glen served as Chief Operating Officer of US Oncology, the country’s largest oncology services organization. Glen previously served in various executive operating positions at some of the country’s largest and most influential healthcare companies including Omnicare, CVS, ProVantage and Caremark. Glen earned his bachelor’s degree in engineering at the University of Illinois and an MBA at the University of Chicago.

Larry Gray is a COO at US Oncology Inc and President & CEO at Farm & Home Publishers Ltd. He has worked as Chief Executive Officer at CareAmerica Health Plans.

Andreas Heid is a Chief Information Officer at US Oncology Inc and is based in Berkeley, California. He has worked as Senior Vice President, Customer Operations at Syapse; Director Business Applications at Siemens; and Software Development & Project Management at Sybit GmbH. Andreas attended University of Applied Sciences, Konstanz between 1996 and 2001; IMD business school between 2006 and 2006; and Siemens Management Consulting between 2007 and 2011.

Daniel D. Von Hoff is the physician in chief and director of translational research at Translational Genomics Research Institute (TGen). He is also a professor of medicine at the Mayo Clinic and medical director of research as well as chief scientific officer at US Oncology. He is most notable for his work in targeted therapies for the treatment of cancer. He led the development of gemcitabine, and has several drugs in development.

Jennifer Jenson is a Chief Therapist / Dosimetrist at US Oncology Inc and Cancer Center Services Senior Dosimetrist at Texas Oncology and is based in Austin, Texas. She attended University of Oklahoma.

Lee Tao is a Chief medical physicist at US Oncology Inc and is based in Longview, Texas , Amerika Serikat.

Loren Rourke is a Chief Surgical Officer at US Oncology Inc and is based in Houston, Texas. She has worked as Regional Breast Program Director at Methodist Hospital; Director, Breast Care Center at Maine Medical Center; and Assistant Professor, Department of Surgical Oncology at MD Anderson Cancer Center. Loren studied at Tulane University, Harvard T.H. Chan School of Public Health between 2016 and 2018, and Louisiana State University School of Medicine in Shreveport between 1996 and 2000.

Michael V. Seiden, MD, PhD is a Senior Vice President & Chief Medical Officer at US Oncology Inc and is based in The Woodlands, Texas.